Author
Listed:
- Donggi Paik
(Harvard Medical School)
- Lina Yao
(Harvard Medical School)
- Yancong Zhang
(Broad Institute of MIT and Harvard
Harvard T. H. Chan School of Public Health)
- Sena Bae
(Harvard T. H. Chan School of Public Health
Harvard T. H. Chan School of Public Health)
- Gabriel D. D’Agostino
(Harvard Medical School)
- Minghao Zhang
(University of Oxford)
- Eunha Kim
(Harvard Medical School)
- Eric A. Franzosa
(Harvard T. H. Chan School of Public Health
Harvard T. H. Chan School of Public Health)
- Julian Avila-Pacheco
(Broad Institute of MIT and Harvard)
- Jordan E. Bisanz
(University of California San Francisco)
- Christopher K. Rakowski
(Bucknell University)
- Hera Vlamakis
(Broad Institute of MIT and Harvard
MIT)
- Ramnik J. Xavier
(Broad Institute of MIT and Harvard
MIT
Massachusetts General Hospital and Harvard Medical School
Massachusetts General Hospital and Harvard Medical School)
- Peter J. Turnbaugh
(University of California San Francisco
Chan Zuckerberg Biohub)
- Randy S. Longman
(Weill Cornell Medicine)
- Michael R. Krout
(Bucknell University)
- Clary B. Clish
(Broad Institute of MIT and Harvard)
- Fraydoon Rastinejad
(University of Oxford)
- Curtis Huttenhower
(Broad Institute of MIT and Harvard
Harvard T. H. Chan School of Public Health
Harvard T. H. Chan School of Public Health)
- Jun R. Huh
(Harvard Medical School
Harvard Medical School and Brigham and Women’s Hospital)
- A. Sloan Devlin
(Harvard Medical School)
Abstract
The microbiota modulates gut immune homeostasis. Bacteria influence the development and function of host immune cells, including T helper cells expressing interleukin-17A (TH17 cells). We previously reported that the bile acid metabolite 3-oxolithocholic acid (3-oxoLCA) inhibits TH17 cell differentiation1. Although it was suggested that gut-residing bacteria produce 3-oxoLCA, the identity of such bacteria was unknown, and it was unclear whether 3-oxoLCA and other immunomodulatory bile acids are associated with inflammatory pathologies in humans. Here we identify human gut bacteria and corresponding enzymes that convert the secondary bile acid lithocholic acid into 3-oxoLCA as well as the abundant gut metabolite isolithocholic acid (isoLCA). Similar to 3-oxoLCA, isoLCA suppressed TH17 cell differentiation by inhibiting retinoic acid receptor-related orphan nuclear receptor-γt, a key TH17-cell-promoting transcription factor. The levels of both 3-oxoLCA and isoLCA and the 3α-hydroxysteroid dehydrogenase genes that are required for their biosynthesis were significantly reduced in patients with inflammatory bowel disease. Moreover, the levels of these bile acids were inversely correlated with the expression of TH17-cell-associated genes. Overall, our data suggest that bacterially produced bile acids inhibit TH17 cell function, an activity that may be relevant to the pathophysiology of inflammatory disorders such as inflammatory bowel disease.
Suggested Citation
Donggi Paik & Lina Yao & Yancong Zhang & Sena Bae & Gabriel D. D’Agostino & Minghao Zhang & Eunha Kim & Eric A. Franzosa & Julian Avila-Pacheco & Jordan E. Bisanz & Christopher K. Rakowski & Hera Vlam, 2022.
"Human gut bacteria produce ΤΗ17-modulating bile acid metabolites,"
Nature, Nature, vol. 603(7903), pages 907-912, March.
Handle:
RePEc:nat:nature:v:603:y:2022:i:7903:d:10.1038_s41586-022-04480-z
DOI: 10.1038/s41586-022-04480-z
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Ethan A. Older & Jian Zhang & Zachary E. Ferris & Dan Xue & Zheng Zhong & Mary K. Mitchell & Michael Madden & Yuzhen Wang & Hexin Chen & Prakash Nagarkatti & Mitzi Nagarkatti & Daping Fan & Melissa El, 2024.
"Biosynthetic enzyme analysis identifies a protective role for TLR4-acting gut microbial sulfonolipids in inflammatory bowel disease,"
Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Xusheng Zhang & Xintong Gao & Zhen Liu & Fei Shao & Dou Yu & Min Zhao & Xiwen Qin & Shuo Wang, 2024.
"Microbiota regulates the TET1-mediated DNA hydroxymethylation program in innate lymphoid cell differentiation,"
Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Guanqun Li & Liwei Liu & Tianqi Lu & Yuhang Sui & Can Zhang & Yongwei Wang & Tao Zhang & Yu Xie & Peng Xiao & Zhongjie Zhao & Chundong Cheng & Jisheng Hu & Hongze Chen & Dongbo Xue & Hua Chen & Gang W, 2023.
"Gut microbiota aggravates neutrophil extracellular traps-induced pancreatic injury in hypertriglyceridemic pancreatitis,"
Nature Communications, Nature, vol. 14(1), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:603:y:2022:i:7903:d:10.1038_s41586-022-04480-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.